Contract Insights

As Coronavirus (COVID-19) is now a global pandemic - with the United States presenting the most significant number of cases - I am reminded of current and past experiences implementing contract management software to help organizations with clinical trials and drug development tracking.  Organizations in the medical field, healthcare, pharmaceuticals, biopharmaceuticals, and other related industries need to effectively manage drug development contracts and obligations, clinical trials, manufacturing of medicine, and key opinion leaders globally.  CobbleStone’s leading enterprise contract lifecycle management software provides the solution to these challenges.

Manually managing purchase orders, bids, vendors, and contracts can be difficult.  Processes that involve paying per solicitation can become extremely costly.  Limited visibility leaves your organization with an imperfect pool of vendors. Hindrances such as an inadequate sourcing platform, an overly complicated procurement system database, and an inefficient contract lifecycle process can prevent your organization from properly administering its contracts.  An effectual source-to-contract process is the solution to the abovementioned issues.  CobbleStone Software’s Contract Insight can provide that solution.

Trusted purchase order management software can reduce administrative costs, promote accountability, improve communication and asset oversight, and help your organization to scale efficiently and effectually.  CobbleStone Software’s Contract Insight can help you to make better purchasing decisions with comprehensive asset lifecycle management.

When purchasing and implementing a new product or service, you want to rest assured that you've chosen an option that will maximize the benefits for your organization.  In the case of contract management software, the decision to make a change often stems from inefficiencies with an organization's contract process.  Thus, the pressure is on to make sure that your organization is attaining the highest possible ROI from a newly deployed source-to-contract software.